Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8571) 8571
Publication (662) 662
Newsletter (329) 329
Book Review (78) 78
Book Chapter (72) 72
Newspaper Article (71) 71
Book / eBook (54) 54
Dissertation (10) 10
Magazine Article (7) 7
Conference Proceeding (4) 4
Data Set (1) 1
Journal / eJournal (1) 1
Reference (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6764) 6764
male (5164) 5164
female (4974) 4974
esophageal cancer (4937) 4937
middle aged (4693) 4693
aged (4195) 4195
index medicus (3921) 3921
esophageal neoplasms - mortality (3603) 3603
cancer (3526) 3526
oncology (3188) 3188
esophageal neoplasms - pathology (3122) 3122
surgery (2950) 2950
adult (2779) 2779
carcinoma, squamous cell - mortality (2727) 2727
prognosis (2604) 2604
esophageal neoplasms - surgery (2421) 2421
carcinoma, squamous cell - pathology (2066) 2066
squamous cell carcinoma (1852) 1852
carcinoma, squamous cell - surgery (1790) 1790
squamous-cell carcinoma (1655) 1655
aged, 80 and over (1608) 1608
neoplasm staging (1601) 1601
survival rate (1593) 1593
retrospective studies (1534) 1534
chemotherapy (1528) 1528
care and treatment (1467) 1467
esophageal squamous cell carcinoma (1441) 1441
esophagus (1438) 1438
research (1416) 1416
esophageal neoplasms - therapy (1359) 1359
treatment outcome (1340) 1340
survival (1332) 1332
mortality (1285) 1285
adenocarcinoma (1237) 1237
esophagectomy (1164) 1164
risk factors (1156) 1156
metastasis (1152) 1152
health aspects (1081) 1081
gastroenterology & hepatology (1065) 1065
carcinoma (1064) 1064
adenocarcinoma - mortality (1041) 1041
follow-up studies (1025) 1025
analysis (1006) 1006
survival analysis (964) 964
carcinoma, squamous cell - therapy (953) 953
radiotherapy (914) 914
esophageal neoplasms - genetics (891) 891
medical prognosis (888) 888
adenocarcinoma - surgery (886) 886
combined modality therapy (878) 878
chemoradiotherapy (871) 871
tumors (860) 860
esophageal neoplasms - drug therapy (853) 853
lymphatic metastasis (819) 819
adenocarcinoma - pathology (791) 791
expression (781) 781
esophageal neoplasms - radiotherapy (755) 755
cancer therapies (715) 715
esophageal neoplasms - metabolism (713) 713
studies (713) 713
patients (711) 711
kaplan-meier estimate (681) 681
carcinoma, squamous cell - genetics (677) 677
immunohistochemistry (677) 677
antineoplastic combined chemotherapy protocols - therapeutic use (645) 645
esophagectomy - methods (638) 638
development and progression (629) 629
genetic aspects (610) 610
carcinoma, squamous cell - metabolism (581) 581
medicine & public health (577) 577
gene expression (575) 575
multivariate analysis (574) 574
therapy (573) 573
carcinoma, squamous cell - drug therapy (563) 563
time factors (557) 557
carcinoma, squamous cell - radiotherapy (552) 552
proportional hazards models (551) 551
disease-free survival (549) 549
esophageal neoplasms - diagnosis (537) 537
diagnosis (524) 524
oncology, experimental (524) 524
neoadjuvant therapy (521) 521
risk (510) 510
proteins (506) 506
prospective studies (504) 504
adenocarcinoma - therapy (502) 502
apoptosis (497) 497
patient outcomes (493) 493
research article (488) 488
esophageal neoplasms - epidemiology (480) 480
radiation therapy (465) 465
medicine (461) 461
cell line, tumor (459) 459
chemoradiation (449) 449
endoscopy (444) 444
epidemiology (434) 434
cisplatin - administration & dosage (432) 432
resection (419) 419
abridged index medicus (418) 418
esophageal carcinoma (408) 408
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (40) 40
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Credit Valley Hospital - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Mt Sinai Hospital - Pathology (1) 1
Scarborough Hospital - General (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8614) 8614
German (181) 181
French (87) 87
Chinese (63) 63
Japanese (57) 57
Spanish (33) 33
Russian (21) 21
Italian (16) 16
Korean (9) 9
Portuguese (7) 7
Hungarian (6) 6
Polish (6) 6
Dutch (5) 5
Swedish (3) 3
Turkish (3) 3
Hebrew (2) 2
Norwegian (2) 2
Romanian (2) 2
Croatian (1) 1
Danish (1) 1
Finnish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Prognostic Impact of Postoperative Complications in 502 Patients with Surgically Resected Esophageal Squamous Cell Carcinoma: A Retrospective Single-institution Study
by Baba, Yoshifumi and Yoshida, Naoya and Shigaki, Hironobu and Iwatsuki, Masaaki and Miyamoto, Yuji and Sakamoto, Yasuo and Watanabe, Masayuki and Baba, Hideo
Annals of Surgery, ISSN 0003-4932, 08/2016, Volume 264, Issue 2, pp. 305 - 311
Objective: To investigate the relationship between postoperative complications and long-term survival in patients with surgically resected esophageal squamous... 
complication | long-term survival | prognosis | pulmonary complication | MORTALITY | SURGERY | GASTROESOPHAGEAL JUNCTION | CHEMORADIOTHERAPY | CANCER | ESOPHAGOGASTRECTOMY | RESPIRATORY COMPLICATIONS | MORBIDITY | PULMONARY COMPLICATIONS | OUTCOMES | Esophagectomy - adverse effects | Humans | Middle Aged | Proportional Hazards Models | Carcinoma, Squamous Cell - surgery | Male | Survival Rate | Treatment Outcome | Postoperative Complications - epidemiology | Carcinoma, Squamous Cell - mortality | Esophageal Neoplasms - surgery | Esophageal Neoplasms - mortality | Female | Aged | Retrospective Studies | Esophageal Squamous Cell Carcinoma
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907)
by Ando, Nobutoshi and Kato, Hoichi and Igaki, Hiroyasu and Shinoda, Masayuki and Ozawa, Soji and Shimizu, Hideaki and Nakamura, Tsutomu and Yabusaki, Hiroshi and Aoyama, Norio and Kurita, Akira and Ikeda, Kenichiro and Kanda, Tatsuo and Tsujinaka, Toshimasa and Nakamura, Kenichi and Fukuda, Haruhiko
Annals of Surgical Oncology, ISSN 1068-9265, 1/2012, Volume 19, Issue 1, pp. 68 - 74
Patients with esophageal carcinoma receiving postoperative chemotherapy showed superior disease-free survival than those receiving surgery alone in a Japan... 
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | PHASE-III TRIAL | SURGERY | CHEMORADIOTHERAPY | ONCOLOGY | SURGICAL-TREATMENT | CANCER | Follow-Up Studies | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Carcinoma, Squamous Cell - surgery | Male | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - surgery | Cisplatin - administration & dosage | Carcinoma, Squamous Cell - mortality | Fluorouracil - administration & dosage | Esophageal Neoplasms - surgery | Esophageal Neoplasms - mortality | Adult | Female | Chemotherapy, Adjuvant | Postoperative Period | Esophagectomy | Survival Rate | Treatment Outcome | Combined Modality Therapy | Carcinoma, Squamous Cell - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Neoplasm Staging | Esophageal Neoplasms - drug therapy | Preoperative Period | Medical colleges | Squamous cell carcinoma | Analysis | Adjuvant treatment | Censorship | Esophageal cancer | Cisplatin | Fluorouracil | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text MicroRNA Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus: Associations with Survival
by Ewy A. Mathà and Giang Huong Nguyen and Elise D. Bowman and Yiqiang Zhao and Anuradha Budhu and Aaron J. Schetter and Rosemary Braun and Mark Reimers and Kensuke Kumamoto and Duncan Hughes and Nasser K. Altorki and Alan G. Casson and Chang-Gong Liu and Xin Wei Wang and Nozomu Yanaihara and Nobutoshi Hagiwara and Andrew J. Dannenberg and Masao Miyashita and Carlo M. Croce and Curtis C. Harris
Clinical Cancer Research, ISSN 1078-0432, 10/2009, Volume 15, Issue 19, pp. 6192 - 6200
Purpose: The dismal outcome of esophageal cancer patients highlights the need for novel prognostic biomarkers, such as microRNAs (miRNA). Although recent... 
microRNA | Barrett's | esophageal cancer | prognosis | expression profiling | DIAGNOSIS | PROFILES | ACTIVATION | METASTASIS | ONCOLOGY | PROGNOSIS | TUMOR-SUPPRESSOR GENE | TARGETS | PROLIFERATION | CANCER | SIGNATURE | Oligonucleotide Array Sequence Analysis | Carcinoma, Squamous Cell - genetics | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Male | Gene Expression Profiling | Barrett Esophagus - pathology | Carcinoma, Squamous Cell - mortality | Esophageal Neoplasms - genetics | Survival Analysis | Aged, 80 and over | Esophageal Neoplasms - mortality | Adult | Female | Adenocarcinoma - genetics | Aged | MicroRNAs - genetics | Barrett Esophagus - genetics | Adenocarcinoma - mortality | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma
by Li, Jiagen and Chen, Zhaoli and Tian, Liqing and Zhou, Chengcheng and He, Max Yifan and Gao, Yibo and Wang, Suya and Zhou, Fang and Shi, Susheng and Feng, Xiaoli and Sun, Nan and Liu, Ziyuan and Skogerboe, Geir and Dong, Jingsi and Yao, Ran and Zhao, Yuda and Sun, Jian and Zhang, Baihua and Yu, Yue and Shi, Xuejiao and Luo, Mei and Shao, Kang and Li, Ning and Qiu, Bin and Tan, Fengwei and Chen, Runsheng and He, Jie
Gut, ISSN 0017-5749, 11/2014, Volume 63, Issue 11, pp. 1700 - 1710
Background Oesophageal cancer is one of the most deadly forms of cancer worldwide. Long non-coding RNAs (lncRNAs) are often found to have important regulatory... 
Oesophageal Cancer | IMPLEMENTATION | GASTROENTEROLOGY & HEPATOLOGY | EXPRESSION | GENOME | INTERGENIC NONCODING RNAS | Carcinoma, Squamous Cell - genetics | Humans | Gene Expression Regulation, Neoplastic | Biomarkers, Tumor - physiology | Gene Expression Profiling | Carcinoma, Squamous Cell - mortality | Esophageal Neoplasms - genetics | Sensitivity and Specificity | Esophageal Neoplasms - mortality | ROC Curve | Retrospective Studies | Transcriptome - physiology | RNA, Long Noncoding - metabolism | Squamous cell carcinoma | Care and treatment | Research | Gene expression | Risk factors | Esophageal cancer | Genomes | Metastasis | Proteins | Studies | Signal transduction | Hospitals | Surgery | Medical prognosis | Cell cycle | Clinical medicine | Signatures | Methods | Cancer | Oesophagus | 1506
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries
by Arnal, María José Domper and Arenas, Ángel Ferrández and Arbeloa, Ángel Lanas
World Journal of Gastroenterology, ISSN 1007-9327, 07/2015, Volume 21, Issue 26, pp. 7933 - 7943
Esophageal cancer is one of the most unknown and deadliest cancers worldwide, mainly because of its extremely aggressive nature and poor survival rate.... 
Adenocarcinoma | Oesophageal cancer | Screening | Barrett's oesophagus | Squamous cell carcinoma | Endoscopic mucosal resection | Early stage | Endoscopic submucosal disection | Epidemiology | SUBMUCOSAL DISSECTION | METAANALYSIS | CHINA | SQUAMOUS-CELL CARCINOMA | SURVEILLANCE | BODY-MASS INDEX | MUCOSAL RESECTION | GASTROENTEROLOGY & HEPATOLOGY | DYSPLASTIC BARRETTS-ESOPHAGUS | Predictive Value of Tests | Adenocarcinoma - pathology | Early Detection of Cancer - methods | Carcinoma, Squamous Cell - pathology | Humans | Risk Factors | Esophageal Neoplasms - ethnology | Carcinoma, Squamous Cell - surgery | Treatment Outcome | Esophagectomy - methods | Carcinoma, Squamous Cell - ethnology | Esophageal Neoplasms - pathology | Esophagoscopy | Incidence | Carcinoma, Squamous Cell - mortality | Esophageal Neoplasms - surgery | Esophageal Neoplasms - mortality | Adenocarcinoma - ethnology | Continental Population Groups | Neoplasm Staging | Adenocarcinoma - mortality | Adenocarcinoma - surgery | Barrett’s oesophagus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Phase II Study of Chemoradiotherapy With 5-Fluorouracil and Cisplatin for Stage II–III Esophageal Squamous Cell Carcinoma: JCOG Trial (JCOG 9906)
by Kato, Ken, M.D and Muro, Kei, M.D and Minashi, Keiko, M.D and Ohtsu, Atsushi, M.D and Ishikura, Satoshi, M.D and Boku, Narikazu, M.D and Takiuchi, Hiroya, M.D and Komatsu, Yoshito, M.D and Miyata, Yoshinori, M.D and Fukuda, Haruhiko, M.D and Gastrointestinal Oncology Study Gr and Japan Clinical Oncology Grp JCOG and Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group (JCOG)
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 81, Issue 3, pp. 684 - 690
Purpose In this Phase II study, we evaluated the efficacy and toxicity of chemoradiotherapy (CRT) with cisplatin (CDDP) and 5-fluorouracil (5-FU) for Stage... 
Radiology | Hematology, Oncology and Palliative Medicine | Esophageal squamous cell carcinoma | Long-term toxicity | Salvage surgery | Chemoradiotherapy | SURGERY | SURVIVAL | THORACIC ESOPHAGUS | CANCER | CHEMOTHERAPY | SALVAGE ESOPHAGECTOMY | RADIATION-THERAPY | ONCOLOGY | CHEMORADIATION | RADIOTHERAPY | DEFINITIVE CHEMORADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Chemoradiotherapy - adverse effects | Age Factors | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cisplatin - administration & dosage | Esophageal Neoplasms - pathology | Carcinoma, Squamous Cell - mortality | Fluorouracil - administration & dosage | Esophageal Neoplasms - mortality | Adult | Female | Surveys and Questionnaires | Esophageal Neoplasms - therapy | Radiotherapy Dosage | Chemoradiotherapy - methods | Drug Administration Schedule | Carcinoma, Squamous Cell - therapy | Survival Rate | Remission Induction | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Health Status | Neoplasm Staging | Salvage Therapy - methods | Preoperative Care - methods | Medical colleges | Chemotherapy | Squamous cell carcinoma | Information services | Clinical trials | Esophageal cancer | Information services industry | Cisplatin | Cancer | Fluorouracil | Index Medicus | ESOPHAGUS | DIGESTIVE SYSTEM | COMPLEXES | HETEROCYCLIC COMPOUNDS | DEATH | INFUSION | MEDICINE | AZINES | ANTIMETABOLITES | FLUOROURACILS | IRRADIATION | ORGANIC HALOGEN COMPOUNDS | HYDROXY COMPOUNDS | THERAPY | DRUGS | RADIOLOGY AND NUCLEAR MEDICINE | PNEUMONITIS | ORGANIC NITROGEN COMPOUNDS | COMBINED THERAPY | RADIOLOGY | URACILS | NEOPLASMS | ORGANIC COMPOUNDS | ORGANIC FLUORINE COMPOUNDS | INTAKE | PYRIMIDINES | TOXICITY | SYMPTOMS | TRANSITION ELEMENT COMPLEXES | PLATINUM COMPLEXES | NUCLEAR MEDICINE | ORGANS | SURVIVAL TIME | DISEASES | CARCINOMAS | NAUSEA | BODY
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Evaluation of the Nodal Status in the 7th Edition of the UICC-TNM Classification for Esophageal Squamous Cell Carcinoma: Proposed Modifications for Improved Survival Stratification
: Impact of Lymph Node Metastases on Overall Survival after Esophagectomy
by Yamasaki, Makoto and Miyata, Hiroshi and Miyazaki, Yasuhiro and Takahashi, Tsuyoshi and Kurokawa, Yukinori and Nakajima, Kiyokazu and Takiguchi, Shuji and Mori, Masaki and Doki, Yuichiro
Annals of Surgical Oncology, ISSN 1068-9265, 9/2014, Volume 21, Issue 9, pp. 2850 - 2856
The 7th edition of the Union for International Cancer Control-TNM (UICC-TNM) classification for esophageal carcinoma made considerable modifications to the... 
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | SURGERY | NUMBER | GASTROESOPHAGEAL JUNCTION | PROGNOSTIC IMPORTANCE | THORACIC ESOPHAGUS | LYMPHADENECTOMY | ONCOLOGY | DISSECTION | SURGICAL RESECTION | AMERICAN JOINT COMMITTEE | NERVE CHAIN | CANCER STAGING SYSTEM | Adenocarcinoma - pathology | Prognosis | Esophagectomy - mortality | Follow-Up Studies | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Carcinoma, Squamous Cell - surgery | Male | Survival Rate | Lymphatic Metastasis | Neoplasm Staging - standards | Lymph Node Excision - mortality | Esophageal Neoplasms - pathology | Carcinoma, Squamous Cell - mortality | Neoplasm Grading | Esophageal Neoplasms - surgery | Aged, 80 and over | Esophageal Neoplasms - mortality | Adult | Female | Aged | Adenocarcinoma - mortality | Adenocarcinoma - surgery
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Meta‐analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro‐oesophageal junctional cancers
by Kumagai, K and Rouvelas, I and Tsai, J. A and Mariosa, D and Klevebro, F and Lindblad, M and Ye, W and Lundell, L and Nilsson, M
British Journal of Surgery, ISSN 0007-1323, 03/2014, Volume 101, Issue 4, pp. 321 - 338
Neither approach increases surgical risk 
PHASE-III TRIAL | SURGERY | SURVIVAL | PREOPERATIVE CHEMOTHERAPY | THORACIC ESOPHAGUS | SQUAMOUS-CELL CARCINOMA | CHEMORADIATION | RANDOMIZED-TRIAL | RADIOTHERAPY | RADIATION-THERAPY | Chemoradiotherapy - adverse effects | Postoperative Complications - etiology | Humans | Risk Factors | Anastomotic Leak - etiology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Carcinoma, Squamous Cell - therapy | Postoperative Complications - mortality | Respiratory Tract Diseases - mortality | Anastomotic Leak - mortality | Randomized Controlled Trials as Topic | Heart Diseases - etiology | Respiratory Tract Diseases - etiology | Carcinoma, Squamous Cell - mortality | Heart Diseases - mortality | Adenocarcinoma - therapy | Esophagogastric Junction - surgery | Chemotherapy, Adjuvant - adverse effects | Esophageal Neoplasms - mortality | Selection Bias | Esophageal Neoplasms - therapy | Adenocarcinoma - mortality | Esophageal Squamous Cell Carcinoma | Squamous cell carcinoma | Patient outcomes | Analysis | Mortality | Adjuvant treatment | Esophageal cancer | Morbidity | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Interaction Between Prediabetes and the ABO Blood Types in Predicting Postsurgical Esophageal Squamous Cell Carcinoma-Specific Mortality: The FIESTA Study
by Fan, GH and Hu, D and Zhang, XR and Peng, F and Lin, XD and Chen, G and Liang, BY and Zhang, HJ and Xia, Y and Zheng, XW and Jie, JZ and Niu, WQ
FRONTIERS IN ONCOLOGY, ISSN 2234-943X, 10/2018, Volume 8, p. 461
Background: We aimed to investigate the interaction between prediabetes and the ABO blood types in predicting esophageal squamous cell carcinoma... 
SURVIVAL | esophageal squamous cell carcinoma | CANCER FIESTA | METFORMIN | prediabetes | the ABO blood type | CHINA | GASTRECTOMY | RISK | prognosis | DIABETES-MELLITUS | ONCOLOGY | the FIESTA study | COLORECTAL-CANCER | PREOPERATIVE METABOLIC SYNDROME | Squamous cell carcinoma | Care and treatment | Prognosis | Patient outcomes | Blood groups | Health aspects | Prediabetic state | Esophageal cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Long Noncoding RNA HOTAIR Is a Prognostic Marker for Esophageal Squamous Cell Carcinoma Progression and Survival
by Lv, Xiao-Bin and Lian, Gui-Yong and Wang, Hao-Ran and Song, Erwei and Yao, Herui and Wang, Ming-Hui
PLoS ONE, ISSN 1932-6203, 05/2013, Volume 8, Issue 5, p. e63516
Background: It is currently unclear whether the expression of HOX transcript antisense RNA (HOTAIR) correlates with the progression of esophageal cancer. The... 
CANCER | MULTIDISCIPLINARY SCIENCES | RNA, Small Interfering - genetics | Gene Expression | Prognosis | Carcinoma, Squamous Cell - metabolism | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Male | Lymphatic Metastasis | RNA, Long Noncoding - genetics | Esophageal Neoplasms - pathology | Gene Knockdown Techniques | Carcinoma, Squamous Cell - mortality | Esophageal Neoplasms - metabolism | Biomarkers, Tumor - metabolism | Cell Line, Tumor | Esophageal Neoplasms - mortality | Carcinoma, Squamous Cell - secondary | Female | Biomarkers, Tumor - genetics | RNA, Long Noncoding - metabolism | Cell Movement | Medical research | Squamous cell carcinoma | Analysis | Medicine, Experimental | DNA polymerases | Development and progression | Antisense RNA | Esophageal cancer | Cell proliferation | Biotechnology | Phosphorylation | RNA-directed DNA polymerase | Transcription | Heart surgery | Metastasis | Tissues | Liver cancer | Cell growth | Cell cycle | Bioindicators | Cell survival | Colonies | Breast cancer | Regression analysis | Gene expression | Ribonucleic acid--RNA | Patients | Survival | Esophagus | Studies | Pancreatic cancer | Medical prognosis | Cell lines | Biomarkers | Cell migration | Cancer | Tumors | RNA | Ribonucleic acid
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor
by Kong, Kar Lok and Kwong, Dora Lai Wan and Chan, Tim Hon-Man and Law, Simon Ying-Kit and Chen, Leilei and Li, Yan and Qin, Yan-Ru and Guan, Xin-Yuan
Gut, ISSN 0017-5749, 01/2012, Volume 61, Issue 1, pp. 33 - 42
Background To understand the involvement of microRNA (miRNA) in the development and progression of oesophageal squamous cell carcinoma (ESCC), miRNA profiles... 
ONCOMIRS | GASTROENTEROLOGY & HEPATOLOGY | PROGRESS | Receptor, IGF Type 1 - metabolism | Prognosis | Oligonucleotide Array Sequence Analysis | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - pathology | Humans | MicroRNAs - metabolism | Esophageal Neoplasms - pathology | Neoplasm Metastasis | Carcinoma, Squamous Cell - mortality | Biomarkers, Tumor - metabolism | Esophageal Neoplasms - mortality | Real-Time Polymerase Chain Reaction | Down-Regulation | Mice, SCID | Blotting, Western | Disease-Free Survival | Animals | Esophageal Neoplasms - genetics | Survival Analysis | Cell Line, Tumor | Mice | Biomarkers, Tumor - chemistry | Methylation | MicroRNAs - chemistry | Squamous cell carcinoma | MicroRNA | Growth | Cancer cells | Causes of | Development and progression | Genetic aspects | Research | Genetic regulation | Health aspects | Liver cancer | Cell growth | Kinases | Rodents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer
by Lim, S.H and Hong, M and Ahn, S and Choi, Y.-L and Kim, K.-M and Oh, D and Ahn, Y.C and Jung, S.-H and Ahn, M.-J and Park, K and Zo, J.I and Shim, Y.M and Sun, J.-M
European Journal of Cancer, ISSN 0959-8049, 2015, Volume 52, pp. 1 - 9
Abstract Background Programmed death-ligand 1 (PD-L1) expression has been suggested as a potential predictive biomarker of response to anti-PD-1/PD-L1 therapy.... 
Hematology, Oncology and Palliative Medicine | PD-L1 expression | Oesophageal squamous cell carcinoma | Neoadjuvant chemoradiotherapy | SURVIVAL | CELLS | SAFETY | PD-1 BLOCKADE | ANTIBODY | ONCOLOGY | IMMUNOTHERAPY | RADIOTHERAPY | ANTI-PD-1 | CARCINOMA | Immunohistochemistry | Up-Regulation | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Male | Chemoradiotherapy, Adjuvant | Esophageal Neoplasms - pathology | Carcinoma, Squamous Cell - mortality | Esophageal Neoplasms - metabolism | Aged, 80 and over | Biomarkers, Tumor - metabolism | Esophageal Neoplasms - mortality | Female | Neoadjuvant Therapy | Retrospective Studies | Chemotherapy, Adjuvant | Esophageal Neoplasms - therapy | Esophageal Squamous Cell Carcinoma | Kaplan-Meier Estimate | Medical Records | Carcinoma, Squamous Cell - therapy | Esophagectomy | Treatment Outcome | B7-H1 Antigen - metabolism | Aged | Medical colleges | Cancer patients | Care and treatment | Squamous cell carcinoma | Chemotherapy | Esophageal cancer | Tumors | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma
by Guo, Yong and Chen, Zhaoli and Zhang, Liang and Zhou, Fang and Shi, Susheng and Feng, Xiaoli and Li, Baozhong and Meng, Xin and Ma, Xi and Luo, Mingyong and Shao, Kang and Li, Ning and Qiu, Bin and Mitchelson, Keith and Cheng, Jing and He, Jie
Cancer Research, ISSN 0008-5472, 01/2008, Volume 68, Issue 1, pp. 26 - 33
Esophageal cancer is the sixth leading cause of death from cancer and one of the least studied cancers worldwide. The global microRNA expression profile of... 
CANCER-CELLS | MICROARRAY | ONCOLOGY | GENE-EXPRESSION | DOWN-REGULATION | CHRONIC LYMPHOCYTIC-LEUKEMIA | PATTERNS | TISSUES | TUMORS | SIGNATURE | CONTROL MAQC PROJECT | Prognosis | Oligonucleotide Array Sequence Analysis | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Male | Gene Expression Profiling | Reverse Transcriptase Polymerase Chain Reaction | Esophageal Neoplasms - pathology | Carcinoma, Squamous Cell - diagnosis | Carcinoma, Squamous Cell - mortality | MicroRNAs - analysis | Survival Analysis | Esophageal Neoplasms - mortality | Adult | Esophageal Neoplasms - diagnosis | Female | MicroRNAs - genetics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights